Literature DB >> 21348891

Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis.

Yoh Zen1, Alberto Quaglia, Bernard Portmann.   

Abstract

AIMS: To explore whether immunoglobulin (Ig)G4-related sclerosing cholangitis (IgG4-SC) contributes to end-stage primary sclerosing cholangitis (PSC) in the United Kingdom. METHODS AND
RESULTS: This study consisted of 41 patients who underwent liver transplantation for advanced PSC. Explanted livers were examined histologically with an emphasis on IgG4-positive plasma cell infiltration. Thirty-nine cases (95%) had minimal or mild infiltration of IgG4-positive plasma cells (≤ 30 cells/high-power field). In contrast, two cases (5%) showed plasma cell IgG4-positivity in more than 100 cells/high-power field. IgG4-positive plasma cells were accumulated preferentially in a (xantho)granulomatous tissue within large bile ducts. Except for the presence of IgG4-positive plasma cells, there was no significant histological difference between IgG4-positive and negative cases. Both showed sclerosing cholangitis with bile duct erosion and xanthogranulomatous reaction more in keeping with PSC than typical IgG4-SC. Clinically, the two patients differed from typical IgG4-related disease, in that both had associated ulcerative colitis, and one of them was younger than expected for IgG4-SC (28 years old).
CONCLUSIONS: No classical IgG4-SC could be identified in patients explanted for PSC. The two cases identified with numerous IgG4-positive plasma cells suggest a superimposed immune mechanism of uncertain nature. A prospective study is needed to assess whether such cases will be steroid-sensitive.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21348891     DOI: 10.1111/j.1365-2559.2011.03763.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  Adult bile duct strictures: differentiating benign biliary stenosis from cholangiocarcinoma.

Authors:  Hiep Nguyen Canh; Kenichi Harada
Journal:  Med Mol Morphol       Date:  2016-06-27       Impact factor: 2.309

2.  Concurrent systemic AA amyloidosis can discriminate primary sclerosing cholangitis from IgG4-associated cholangitis.

Authors:  Takehiro Kato; Atsumasa Komori; Sung-Kwan Bae; Kiyoshi Migita; Masahiro Ito; Yasuhide Motoyoshi; Seigo Abiru; Hiromi Ishibashi
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

Review 3.  IgG4-related hepatobiliary disease: an overview.

Authors:  Emma L Culver; Roger W Chapman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

4.  Lymphoplasmacytic sclerosing pancreatitis without IgG4 tissue infiltration or serum IgG4 elevation: IgG4-related disease without IgG4.

Authors:  Phil A Hart; Thomas C Smyrk; Suresh T Chari
Journal:  Mod Pathol       Date:  2014-08-01       Impact factor: 7.842

5.  IgG4 Cholangiopathy.

Authors:  Yoh Zen; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-04

Review 6.  Cholangiocarcinoma with respect to IgG4 Reaction.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2014-07-15

Review 7.  Review of primary sclerosing cholangitis with increased IgG4 levels.

Authors:  Charis D Manganis; Roger W Chapman; Emma L Culver
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

Review 8.  The Role of B Cells in Adult and Paediatric Liver Injury.

Authors:  Arzoo M Patel; Yuxin S Liu; Scott P Davies; Rachel M Brown; Deirdre A Kelly; Dagmar Scheel-Toellner; Gary M Reynolds; Zania Stamataki
Journal:  Front Immunol       Date:  2021-09-23       Impact factor: 8.786

9.  Single cell T cell landscape and T cell receptor repertoire profiling of AML in context of PD-1 blockade therapy.

Authors:  Hussein A Abbas; Dapeng Hao; Katarzyna Tomczak; Praveen Barrodia; Jin Seon Im; Patrick K Reville; Zoe Alaniz; Wei Wang; Ruiping Wang; Feng Wang; Gheath Al-Atrash; Koichi Takahashi; Jing Ning; Maomao Ding; Hannah C Beird; Jairo T Mathews; Latasha Little; Jianhua Zhang; Sreyashi Basu; Marina Konopleva; Mario L Marques-Piubelli; Luisa M Solis; Edwin Roger Parra; Wei Lu; Auriole Tamegnon; Guillermo Garcia-Manero; Michael R Green; Padmanee Sharma; James P Allison; Steven M Kornblau; Kunal Rai; Linghua Wang; Naval Daver; Andrew Futreal
Journal:  Nat Commun       Date:  2021-10-18       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.